| Name | 2-hydroxypropane-1,2,3-tricarboxylic acid,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide |
|---|---|
| Synonyms |
EINECS 262-295-4
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidyl]-N-phenylpropanamide citrate UNII-S9ZFX8403R N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide citrate Sufentanyl citrate sufentanil citrate Sufenta N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl}-N-phenylpropionamide citrate N-[4-(methoxymethy)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide 2-hydroxy-1,2,3-propanetricarboxylate Fentatienil sufentanil cytrate |
| Boiling Point | 493.1ºC at 760 mmHg |
|---|---|
| Melting Point | 96.6ºC |
| Molecular Formula | C28H38N2O9S |
| Molecular Weight | 578.67400 |
| Flash Point | 252ºC |
| Exact Mass | 578.23000 |
| PSA | 193.15000 |
| LogP | 2.90420 |
| Appearance | white to beige |
| Storage condition | -20°C Freezer |
| Water Solubility | H2O: soluble1mg/mL, clear |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Hazard Codes | T+,T,F |
| Risk Phrases | 26/27/28-39/23/24/25-23/24/25-11 |
| Safety Phrases | 26-27-28-36/37/39-45-36/37-16-7 |
| RIDADR | UN 3249 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
|
~55%
60561-17-3 |
| Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2010/16365 A1, 2010 ; Location in patent: Page/Page column 27 ; US 20100016365 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |